Compound class:
Natural product
Comment: Caprazamycin B is a liponucleoside antibacterial compound, with activity against Gram-positive bacteria and mycobacteria, that was obtained from the culture broth of the actinomycete strain Streptomyces sp. MK730-62F2 [3-4]. It inhibits phospho-N-acetylmuramoyl-pentapeptide-transferase (MraY, translocase I) [5], an essential enzyme in bacterial peptidoglycan biosynthesis.
|
|
No information available. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
Caprazamycin B is one of a number of nucleoside antibacterial natural products that interfere with bacterial cell wall synthesis by inhibiting phospho-N-acetylmuramoyl-pentapeptide-transferase (MraY). This essential enzyme catalyzes the first reaction in the biosynthesis of the cell wall peptidoglycan, transfering the peptidoglycan precursor phospho-MurNAc-pentapeptide to the membrane lipid carrier undecaprenyl phosphate, yielding undecaprenyl-pyrophosphoryl-MurNAc-pentapeptide (lipid I) [1-2,6]. |